These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12472903)

  • 21. Methods for measuring tau pathology in transgenic mouse models.
    Forest SK; Acker CM; d'Abramo C; Davies P
    J Alzheimers Dis; 2013; 33(2):463-71. PubMed ID: 22976073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model.
    Ferrer I; Andrés-Benito P; Ausín K; Cartas-Cejudo P; Lachén-Montes M; Del Rio JA; Fernández-Irigoyen J; Santamaría E
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition.
    Eskandari-Sedighi G; Daude N; Gapeshina H; Sanders DW; Kamali-Jamil R; Yang J; Shi B; Wille H; Ghetti B; Diamond MI; Janus C; Westaway D
    Mol Neurodegener; 2017 Oct; 12(1):72. PubMed ID: 28978354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.
    Hart de Ruyter FJ; Morrema THJ; den Haan J; ; Twisk JWR; de Boer JF; Scheltens P; Boon BDC; Thal DR; Rozemuller AJ; Verbraak FD; Bouwman FH; Hoozemans JJM
    Acta Neuropathol; 2023 Feb; 145(2):197-218. PubMed ID: 36480077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical Distribution of Tau Protein in Synaptosomal Fraction of Transgenic Mice Expressing Human P301L Tau.
    Sahara N; Murayama M; Higuchi M; Suhara T; Takashima A
    Front Neurol; 2014; 5():26. PubMed ID: 24653715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice.
    Hosokawa M; Arai T; Masuda-Suzukake M; Kondo H; Matsuwaki T; Nishihara M; Hasegawa M; Akiyama H
    J Neuropathol Exp Neurol; 2015 Feb; 74(2):158-65. PubMed ID: 25575133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylene blue reduced abnormal tau accumulation in P301L tau transgenic mice.
    Hosokawa M; Arai T; Masuda-Suzukake M; Nonaka T; Yamashita M; Akiyama H; Hasegawa M
    PLoS One; 2012; 7(12):e52389. PubMed ID: 23285020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease.
    Ke YD; Delerue F; Gladbach A; Götz J; Ittner LM
    PLoS One; 2009 Nov; 4(11):e7917. PubMed ID: 19936237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau filament formation in transgenic mice expressing P301L tau.
    Götz J; Chen F; Barmettler R; Nitsch RM
    J Biol Chem; 2001 Jan; 276(1):529-34. PubMed ID: 11013246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assembly of two distinct dimers and higher-order oligomers from full-length tau.
    Sahara N; Maeda S; Murayama M; Suzuki T; Dohmae N; Yen SH; Takashima A
    Eur J Neurosci; 2007 May; 25(10):3020-9. PubMed ID: 17561815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
    Matsumoto G; Matsumoto K; Kimura T; Suhara T; Higuchi M; Sahara N; Mori N
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum.
    Andrés-Benito P; Carmona M; Jordán M; Fernández-Irigoyen J; Santamaría E; Del Rio JA; Ferrer I
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy.
    Delobel P; Lavenir I; Fraser G; Ingram E; Holzer M; Ghetti B; Spillantini MG; Crowther RA; Goedert M
    Am J Pathol; 2008 Jan; 172(1):123-31. PubMed ID: 18079436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy.
    Zimova I; Brezovakova V; Hromadka T; Weisova P; Cubinkova V; Valachova B; Filipcik P; Jadhav S; Smolek T; Novak M; Zilka N
    J Alzheimers Dis; 2016 Sep; 54(2):831-43. PubMed ID: 27567836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
    Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
    J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
    Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
    Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-cycle markers in a transgenic mouse model of human tauopathy: increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.
    Delobel P; Lavenir I; Ghetti B; Holzer M; Goedert M
    Am J Pathol; 2006 Mar; 168(3):878-87. PubMed ID: 16507903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.
    Strang KH; Goodwin MS; Riffe C; Moore BD; Chakrabarty P; Levites Y; Golde TE; Giasson BI
    Acta Neuropathol Commun; 2017 Jul; 5(1):58. PubMed ID: 28760159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.